A 52-year-old man with a 10-year history of peptic ulcer disease presents with recurrent symptoms despite adherence to H2-receptor antagonists. His endoscopy confirms active ulceration. The structure marked **A** in the diagram represents the final common pathway for gastric acid secretion. Which of the following drugs would be most effective in inhibiting this structure and why?